WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007085969) INFLUENZA VACCINES CONTAINING HEMAGGLUTININ AND MATRIX PROTEINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/085969    International Application No.:    PCT/IB2007/001150
Publication Date: 02.08.2007 International Filing Date: 26.01.2007
Chapter 2 Demand Filed:    21.12.2007    
IPC:
A61K 39/145 (2006.01)
Applicants: NOVARTIS VACCINES AND DIAGNOSTICS GMBH & CO KG [DE/DE]; Emil-von-Behring-Strasse 76, 35041 Marburg (DE) (For All Designated States Except US).
BROEKER, Michael [DE/DE]; (DE) (For US Only).
KOST, Holger [DE/DE]; (DE) (For US Only)
Inventors: BROEKER, Michael; (DE).
KOST, Holger; (DE)
Agent: MARSHALL, Cameron, John; Carpmaels & Ransford, 43-45 Bloomsbury Square, London WC1A 2RA (GB)
Priority Data:
0601733.9 27.01.2006 GB
0620175.0 11.10.2006 GB
Title (EN) INFLUENZA VACCINES CONTAINING HEMAGGLUTININ AND MATRIX PROTEINS
(FR) VACCINS CONTRE LA GRIPPE CONTENANT DES HÉMAGLUTININES ET DES PROTÉINES MATRICIELLES
Abstract: front page image
(EN)An immunogenic composition comprising influenza virus haemagglutinin and matrix proteins. These may be from influenza viruses grown in cell culture rather than eggs. The matrix protein may be a fragment of a full-length viral matrix protein e.g. a matrix M1 fragment with a molecular weight of less than 2OkDa. The composition may be a subunit vaccine comprising purified surface glycoproteins.
(FR)L'invention concerne une composition immunogène qui comprend des hémaglutinines et des protéines matricielles du virus de la grippe. Ces dernières peuvent être extraites de virus de la grippe issus de cultures cellulaires plutôt que d'oeufs. La protéine matricielle peut être un fragment d'une protéine matricielle virale de pleine longueur, p.ex. un fragment matriciel M1 d'un poids moléculaire inférieur à 20 kDa. La composition peut être un vaccin de sous-unités renfermant des glycoprotéines de surface purifiées.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)